{
    "eid": "2-s2.0-85138029142",
    "title": "Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases",
    "cover-date": "2022-09-20",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Chemistry (all)",
            "@code": "1600",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemical Engineering (all)",
            "@code": "1500",
            "@abbrev": "CENG"
        }
    ],
    "keywords": [],
    "authors": [
        "Kamonpan Sanachai",
        "Panupong Mahalapbutr",
        "Kowit Hengphasatporn",
        "Yasuteru Shigeta",
        "Supaphorn Seetaha",
        "Lueacha Tabtimmai",
        "Thierry Langer",
        "Peter Wolschann",
        "Tanakorn Kittikool",
        "Sirilata Yotphan",
        "Kiattawee Choowongkomon",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 4,
    "ref-count": 85,
    "ref-list": [
        "Janus kinases in immune cell signaling",
        "Advances in the Discovery of Selective JAK Inhibitors",
        "A road map for those who don't know JAK-STAT",
        "Characterization and analysis of the proximal Janus kinase 3 promoter",
        "Biology and significance of the JAK/STAT signalling pathways",
        "BCR-ABL1-negative myeloproliferative neoplasms: A review of molecular biology, diagnosis, and treatment",
        "Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders",
        "IL-6 in Inflammation, Immunity, and Disease",
        "The granulocyte-macrophage colony-stimulating factor receptor: Linking its structure to cell signaling and its role in disease",
        "JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders",
        "Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy (vol 132, pg 694, 2018)",
        "GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation",
        "A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions",
        "Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells",
        "Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities",
        "Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach",
        "Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma",
        "Janus Kinase 3-Activating Mutations Identified in Natural Killer/T-cell Lymphoma",
        "JAK-STAT signaling in cancer: From cytokines to non-coding genome",
        "Molecular Pathways: Molecular Basis for Sensitivity and Resistance to JAK Kinase Inhibitors",
        "Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases",
        "JAK-STAT pathway targeting for the treatment of inflammatory bowel disease",
        "Ruxolitinib",
        "Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases",
        "JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders",
        "Pyridone 6, a pan-janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells",
        "Flavonoids in Inflammatory Bowel Disease: A Review",
        "Inhibitors of JAK-family kinases: An update on the patent literature 2013-2015, part 1",
        "Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2",
        "Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors",
        "Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1H)-pyrazole Derivatives as JAKs Inhibitors",
        "Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2",
        "Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors",
        "Novel Hinge-Binding Motifs for Janus Kinase 3 Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres",
        "Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): Designing by pharmacophore- and docking-based virtual screening approach",
        "Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases",
        "An introduction to ROC analysis",
        "Multiple Virtual Screening Strategies for the Discovery of Novel Compounds Active Against Dengue Virus: A Hit Identification Study",
        "Development and validation of a genetic algorithm for flexible docking",
        "A fast flexible docking method using an incremental construction algorithm",
        "Protein kinase biochemistry and drug discovery",
        "Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1H)-pyrazole Derivatives as JAKs Inhibitors",
        "Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors",
        "Dibromopinocembrin and Dibromopinostrobin Are Potential Anti-Dengue Leads with Mild Animal Toxicity",
        "Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main Protease",
        "Looking Back, Looking Forward at Halogen Bonding in Drug Discovery",
        "Lead- and drug-like compounds: The rule-of-five revolution",
        "The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1 H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties",
        "Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders",
        "Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors",
        "Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases",
        "Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening",
        "Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains",
        "Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques",
        "FDA-approved small-molecule kinase inhibitors",
        "Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures",
        "Discovery of 5 Chloro-N-2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N-4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway",
        "A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia",
        "Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases",
        "Copper/Persulfate-Promoted Oxidative Decarboxylative C-H Acylation of Pyrazolones with alpha-Oxocarboxylic Acids: Direct Access to 4-Acylpyrazolones under Mild Conditions",
        "Metal-Free Direct C-H Thiolation and Thiocyanation of Pyrazolones",
        "DABCO-catalyzed silver-promoted direct thiolation of pyrazolones with diaryl disulfides",
        "LigandScout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters",
        "KNIME-CDK: Workflow-driven cheminformatics",
        "A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2",
        "DecoyFinder: An easy-to-use python GUI application for building target-specific decoy sets",
        "A fast flexible docking method using an incremental construction algorithm",
        "Improved protein-ligand docking using GOLD",
        "Comparative study of several algorithms for flexible ligand docking",
        "UCSF chimera - A visualization system for exploratory research and analysis",
        "CAESAR: A new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration",
        "SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules",
        "Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB",
        "Development and testing of a general amber force field",
        "Particle Mesh Ewald - An N.Log(N) Method for Ewald Sums in Large Systems",
        "Thermostat algorithms for molecular dynamics simulations",
        "LINCS: A linear constraint solver for molecular simulations",
        "Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2 '-O-Methyltransferase",
        "Rosmarinic Acid as a Potent Influenza Neuraminidase Inhibitor: In Vitro and in Silico Study",
        "Binding Hotspot and Activation Mechanism of Maltitol and Lactitol toward the Human Sweet Taste Receptor",
        "Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation",
        "PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data",
        "MMPBSA.py: An Efficient Program for End-State Free Energy Calculations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60025988",
            "affilname": "Universit\u00e4t Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025988",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60103462",
            "affilname": "King Mongkut's University of Technology North Bangkok",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103462",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Tsukuba",
            "@id": "60014256",
            "affilname": "University of Tsukuba",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014256",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fundamental Fund of Khon Kaen University",
        "NSRF",
        "National Science, Research and Innovation Fund",
        "Science Achievement Scholarship of Thailand",
        "Thailand Science Research and Innovation Fund Chulalongkorn University",
        "National Research Council of Thailand",
        "Kasetsart University Research and Development Institutes"
    ]
}